2026 ICD-10-CM Diagnosis Code B42.7Disseminated sporotrichosis

ICD-10-CM CodesA00–B99B35-B49B42

ICD-10-CM B42.7
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

B42.7 is a billable ICD-10-CM diagnosis code for disseminated sporotrichosis. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 867 through 869. Coders also document this condition as cutaneous sporotrichosis. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Fungal infections.

Code Identity

ICD-10-CM Code
B42.7
Billable Status
Yes — Valid for Submission
Code Describes
Disseminated sporotrichosis
Short Description
Disseminated sporotrichosis
Same as the full description in the CMS dataset.
Parent Code
Sporotrichosis

Code Classification

ChapterA00–B99Certain infectious and parasitic diseases
SectionB35-B49Mycoses
CategoryB42Sporotrichosis
This CodeB42.7Disseminated sporotrichosis

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Cutaneous sporotrichosis
  • Disseminated cutaneous mycosis
  • Disseminated cutaneous sporotrichosis
  • Disseminated sporotrichosis

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Generalized sporotrichosis

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Sporotrichosis
      • disseminated
    • Sporotrichosis
      • generalized

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INF004
Fungal infections
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Sporotrichosis

    the commonest and least serious of the deep mycoses, characterized by nodular lesions of the cutaneous and subcutaneous tissues. it is caused by inhalation of contaminated dust or by infection of a wound with sporothrix.
  • Sporothrix

    a mitosporic ophiostomataceae fungal genus, whose species sporothrix schenckii is a well-known animal pathogen. the conidia of this soil fungus may be inhaled causing a primary lung infection, or may infect independently via skin punctures.

Patient EducationClinical

Fungal Infections

If you have ever had athlete's foot or a yeast infection, you can blame a fungus. A fungus is a primitive organism. Mushrooms, mold and mildew are examples. Fungi live in air, in soil, on plants and in water. Some live in the human body. Only about half of all types of fungi are harmful.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert B42.7 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
117.1 Sporotrichosis
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About B42.7Overview

Is B42.7 (Sporotrichosis) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report disseminated sporotrichosis on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does B42.7 group to?

When disseminated sporotrichosis is the principal diagnosis on an inpatient stay, it groups to MS-DRG 867, 868, 869, with relative weights from 0.7297 to 2.0932 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of B42.7?

Under the General Equivalence Mappings, disseminated sporotrichosis converts to ICD-9-CM 117.1 (sporotrichosis). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.